Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Deployment of technologies for the reduction of falls: The European project I-DONT-FALL

2nd International Conference and Expo on Novel Physiotherapies

Yannis Dionyssiotis

Singular Logic, Greece SPC, Greece

ScientificTracks Abstracts: J Nov Physiother

DOI: 10.4172/2165-7025.C1.005

Abstract
I DONT FALL (Integrated prevention and Detection solutions Tailored to the population and risk factors associated with falls) aims to develop, implement and evaluate individualized services for old people for the prevention of falls, with the application of physical and cognitive exercise programs, using modern technologies. This clinical trial started in May 2012 involving 500 users across seven pilot sites in four countries. Subjects (fallers or sedentary old people aged all above 65 years), were randomized into 4 groups of 125 subjects in the form of individual sessions twice weekly of cognitive and/or motor training according to the subgroup to which they were randomized (each one 24 sessions/in 3 months). The principal outcome for the study is reduction of number of falls, risk of falling and fear of falling between experimental and control group. On outcome of fear of falling measured by Falls Efficacy Scale (FES) we found a significant reduction for groups that per-formed the mixed and motor treatment (p=0.05; p=0.004). On the outcome of risk of falling measured by Tinetti scale, we found a significant reduction for groups that performed the mixed treatment (p=0.04). Mobility measured by 6 minutes walking test (6MWT) and cognitive executive functions measured by Trail Making Test part B (TMT B) were generally improved by any kind of treatment (p=0.06; p=0.04) but not by the placebo. Finally, we observed no changes on global cognition and functional abilities for any condition.
Biography

Yannis Dionyssiotis is specialized in Physical Medicine and Rehabilitation. He has clinical experience as physiatrist in a variety of clinical settings as clinician, researcher, clinical instructor and consultant in Greece and Germany. He also holds a thesis in SCI induced Osteoporosis and Metabolic Bone Diseases from Athens University and a Senior European Board Certification in PRM (certified 2005). He has published more than 25 papers in reputed journals and has been serving as an Editorial Board Member of repute. He won the Heim Ring Silver award in 2010 and the European Board PRM award in Bruges in 2008.

Email: yannis_dionyssiotis@hotmail.com

Relevant Topics
Top